Back to results
US 2025/0367169 A1Published application
Formulations for personalized methods of treatment
AssigneeFaeth Therapeutics, Inc.
InventorOliver D.K. Maddocks
Life of this patent
Estimating the term…
Abstract
Disclosed herein are formulations and methods of administering formulations to starve cells of nutrients, such as amino acids. The formulations of the present invention can be substantially be devoid of one or more non-essential amino acids.
Claims20
1-43. (canceled)
A composition for treating a patient with cancer comprising in unit dosage form:
- a) a non-essential amino acid comprising alanine or a salt thereof in an amount from about 4% to about 8% (w/w), wherein the non-essential amino acid or the salt thereof is not part of a polypeptide;
- b) a first essential amino acid comprising lysine or a salt thereof in an amount from about 8% to about 12% (w/w) and a second essential amino acid comprising leucine or a salt thereof in an amount from about 6% to about 11% (w/w), wherein the first essential amino acid or the salt thereof and the second essential amino acid or the salt thereof are not part of a polypeptide;
- and
- c) a pharmaceutically acceptable excipient,
- wherein the composition is devoid of proline and salts thereof.
2 more elements
Dependencies are inferred from the claim text.